217 related articles for article (PubMed ID: 15526248)
1. Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.
Voors AA; van Geel PP; Oosterga M; Buikema H; van Veldhuisen DJ; van Gilst WH
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):130-4. PubMed ID: 15526248
[TBL] [Abstract][Full Text] [Related]
2. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery.
Dayi SU; Tartan Z; Terzi S; Kasikcioglu H; Uyarel H; Orhan G; Alper AT; Ciloglu F; Cam N
Heart Surg Forum; 2005; 8(5):E373-7. PubMed ID: 16146835
[TBL] [Abstract][Full Text] [Related]
3. [Effect of the polymorphism of the angiotensin-converting enzyme gene on the drug treatment in patients with chronic heart failure].
Huang WY; Sun M; Zhou HY; Pei ZF; Yang TL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):686-9. PubMed ID: 16114558
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.
Vegter S; Perna A; Hiddema W; Ruggenenti P; Remuzzi G; Navis G; Postma MJ
Pharmacogenet Genomics; 2009 Sep; 19(9):695-703. PubMed ID: 19696696
[TBL] [Abstract][Full Text] [Related]
5. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA
Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432
[TBL] [Abstract][Full Text] [Related]
6. Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure.
Tang WH; Vagelos RH; Yee YG; Fowler MB
Am Heart J; 2004 Nov; 148(5):889-94. PubMed ID: 15523323
[TBL] [Abstract][Full Text] [Related]
7. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
8. The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study.
Ay C; Bencur P; Vormittag R; Sailer T; Jungbauer C; Vukovich T; Mannhalter C; Pabinger I
Thromb Haemost; 2007 Oct; 98(4):777-82. PubMed ID: 17938801
[TBL] [Abstract][Full Text] [Related]
9. ACE ID genotype and the muscle strength and size response to unilateral resistance training.
Pescatello LS; Kostek MA; Gordish-Dressman H; Thompson PD; Seip RL; Price TB; Angelopoulos TJ; Clarkson PM; Gordon PM; Moyna NM; Visich PS; Zoeller RF; Devaney JM; Hoffman EP
Med Sci Sports Exerc; 2006 Jun; 38(6):1074-81. PubMed ID: 16775548
[TBL] [Abstract][Full Text] [Related]
10. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
[TBL] [Abstract][Full Text] [Related]
11. Relation between angiotensin-converting enzyme I/D gene polymorphism and pulse pressure in patients with a first anterior acute myocardial infarction.
Oztürk O; Oztürk U
Anadolu Kardiyol Derg; 2009 Feb; 9(1):9-14. PubMed ID: 19196567
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
[TBL] [Abstract][Full Text] [Related]
13. BANFF: an update.
Anderson T
Can J Cardiol; 1999 Apr; 15 Suppl B():29B-30B. PubMed ID: 10350682
[TBL] [Abstract][Full Text] [Related]
14. [Effect of the polymorphism of the angiotensin-converting enzyme gene on the plasma angiotensin II levels and the risk of chronic heart failure].
Huang WY; Sun M; Zhou HY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):198-200. PubMed ID: 16145913
[TBL] [Abstract][Full Text] [Related]
15. The ACE gene polymorphism and cough threshold for capsaicin after cilazapril usage.
Takahashi T; Yamaguchi E; Furuya K; Kawakami Y
Respir Med; 2001 Feb; 95(2):130-5. PubMed ID: 11217909
[TBL] [Abstract][Full Text] [Related]
16. Interaction of implantable defibrillator therapy with angiotensin-converting enzyme deletion/insertion polymorphism.
Bedi MS; Postava LA; Murali S; Macgowan GA; Mathier M; McNamara DM; London B
J Cardiovasc Electrophysiol; 2004 Oct; 15(10):1162-6. PubMed ID: 15485441
[TBL] [Abstract][Full Text] [Related]
17. Neutral endopeptidase and angiotensin I converting enzyme insertion/deletion gene polymorphism in humans.
Jalil JE; Ocaranza MP; Oliveri C; Córdova S; Godoy I; Chamorro G; Braun S; Fardella C; Michel JB; Lavandero S
J Hum Hypertens; 2004 Feb; 18(2):119-25. PubMed ID: 14730327
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 and vasopressin plasma levels are not associated with the insertion/deletion polymorphism of the human angiotensin I-converting enzyme gene in patients with coronary artery disease.
Al-Fakhri N; Linhart RE; Philipp M; Heidt M; Hehrlein FW; Gardemann A; Katz N
J Hum Hypertens; 2003 Feb; 17(2):133-8. PubMed ID: 12574792
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme insertion/deletion genotype is associated with the activities of plasma coagulation factor VII and X independent of triglyceride metabolism.
Okura Y; Hayashi K; Shingu T; Kuga Y; Nomura S; Kajiyama G; Nakashima Y; Saku K
Coron Artery Dis; 2003 Jun; 14(4):285-91. PubMed ID: 12826927
[TBL] [Abstract][Full Text] [Related]
20. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
